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RET Signaling Is Required for Survival and Normal Function
of Nonpeptidergic Nociceptors
Judith P. Golden,1 Masato Hoshi,2 Mohammed A. Nassar,8 Hideki Enomoto,7 John N. Wood,8,9 Jeffrey Milbrandt,3,6
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Nociception Group, Department of Biology, University College London, London WC1E 6BT, United Kingdom, and 9Department of Molecular Medicine,
Seoul National University, Seoul 151-742, Korea
1

Small unmyelinated sensory neurons classified as nociceptors are divided into two subpopulations based on phenotypic differences,
including expression of neurotrophic factor receptors. Approximately half of unmyelinated nociceptors express the NGF receptor TrkA,
and half express the GDNF family ligand (GFL) receptor Ret. The function of NGF/TrkA signaling in the TrkA population of nociceptors
has been extensively studied, and NGF/TrkA signaling is a well established mediator of pain. The GFLs are analgesic in models of
neuropathic pain emphasizing the importance of understanding the physiological function of GFL/Ret signaling in nociceptors. However,
perinatal lethality of Ret-null mice has precluded the study of the physiological role of GFL/Ret signaling in the survival, maintenance, and
function of nociceptors in viable mice. We deleted Ret exclusively in nociceptors by crossing nociceptor-specific Nav1.8 Cre and Ret
conditional mice to produce Ret-Nav1.8 conditional knock-out (CKO) mice. Loss of Ret exclusively in nociceptors results in a reduction in
nociceptor number and size, indicating that Ret signaling is important for the survival and trophic support of these cells. Ret-Nav1.8 CKO
mice exhibit reduced epidermal innervation but normal central projections. In addition, Ret-Nav1.8 CKO mice have increased sensitivity
to cold and increased formalin-induced pain, demonstrating that Ret signaling modulates the function of nociceptors in vivo. Enhanced
inflammation-induced pain may be mediated by decreased prostatic acid phosphatase (PAP), as PAP levels are markedly reduced in
Ret-Nav1.8 CKO mice. The results of this study identify the physiological role of endogenous Ret signaling in the survival and function of
nociceptors.

Introduction
During embryonic development, small-diameter sensory neurons in the dorsal root ganglion (DRG) that are classified as nociceptors express the NGF receptor TrkA and depend on NGF for
survival (Johnson et al., 1980; Crowley et al., 1994; Silos-Santiago
et al., 1995). During late embryonic and early postnatal life,
small-diameter unmyelinated nociceptors (C-fiber nociceptors)
diverge into two subpopulations (Molliver et al., 1997). One population continues to express TrkA. In the other population, TrkA
expression is downregulated and Ret, the signaling receptor for
the GDNF family ligands (GFLs), is upregulated. Nociceptors
that express TrkA express neuropeptides, do not bind the lectin
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isolectin B4 (IB4), do not express thiamine monophosphatase
(TMP), and project to lamina I and lamina II outer (IIo) of the
dorsal horn, while nociceptors that express Ret do not typically
express neuropeptides, do bind IB4, do express TMP, and
project to lamina II inner (IIi) of the dorsal horn (Molliver et
al., 1997; Braz et al., 2002; Zylka et al., 2005). While much is
known about the role of NGF/TrkA signaling in the TrkA
population of C-fiber nociceptors, notably the well established
role of NGF/TrkA signaling in pain (Pezet and McMahon,
2006), little is known of the physiological role of GFL/Ret
signaling in the Ret population.
The GFL family includes the following: glial cell line-derived
neurotrophic factor (GDNF), neurturin (NRTN), artemin
(ARTN), and persephin (PSPN) (Airaksinen and Saarma, 2002).
The GFL receptor is a complex consisting of a signaling component, the receptor tyrosine kinase Ret, and a ligand-binding component, a cell surface receptor called GDNF family receptor ␣
(GFR␣1-4) (Airaksinen and Saarma, 2002). Each GFR␣ coreceptor binds with high affinity to one of the four ligands and confers
ligand specificity to the receptor complex: GDNF-GFR␣1,
NRTN-GFR␣2, ARTN-GFR␣3, and PSPN-GFR␣4. Ret is the
common signaling component of all GFL receptor complexes
and is required in partnership with a GFR␣ coreceptor to form a
functional receptor complex.
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GFL/Ret signaling influences sensory neuron survival as well
as sensory neuron structure and function in many experimental
paradigms (Bennett et al., 1998b, 2000; Airaksinen and Saarma,
2002; Ernsberger, 2008; Malin and Davis, 2008). Perinatal death
of Ret-null mice has precluded study of the physiological function of Ret in mature sensory neurons (Schuchardt et al., 1994).
To overcome this limitation, we deleted Ret exclusively in the
nonpeptidergic IB4-binding subpopulation of C-fiber nociceptors by crossing mice harboring a conditional RET allele (Jain et
al., 2006) with mice expressing Cre recombinase under the sodium channel ␣ subunit 1.8 promoter (Nav1.8-Cre) (Stirling et
al., 2005), which is expressed exclusively in nociceptors. Analysis
of these mice reveals that Ret is required for the survival, trophic
maintenance, and normal function of IB4 nociceptors.

Materials and Methods
Animal generation. Institution approved protocols were followed for all
animal studies. Generation of Ret conditional mice with a floxed human
RET9 allele followed by the EGFP reporter for identification of cells with
Ret deletion were generated as previously described (Jain et al., 2006). To
produce mice with conditional Ret deletion in nociceptors, heterozygous
mice with one Ret-null allele (RetTGM or Ret lacz) (Enomoto et al., 2001;
Gould et al., 2008) knocked into the Ret locus were crossed with
Nav1.8Cre/⫹ mice (Stirling et al., 2005) to produce double heterozygous mice
(Ret⫹/⫺:Nav1.8Cre/⫹). Double heterozygous mice were then crossed with Ret
conditional mice (RetRETfloxEGFP/⫹) to produce Ret-Nav1.8 conditional
knock-out (CKO) mice (RetRETfloxEGFP/⫺:Nav1.8Cre/⫹) and Ret-Nav1.8 heterozygous control (Het) mice (RetRETfloxEGFP/⫹:Nav1.8Cre/⫹). Note that
EGFP reporter expression in these mice indicates that Cre-mediated deletion
of the floxed allele has occurred.
Behavior testing. Behavior testing was performed using male and female mice 7–10 weeks of age. Littermates or age-matched control mice of
the appropriate genotypes were used. Ret-Nav1.8 CKO mice (RetRETfloxEGFP/⫺:
Nav1.8Cre/⫹) were compared with control mice that harbor at least one
functional Ret allele in nonpeptidergic nociceptors. Control mice include
Ret-Nav1.8 Het mice (RetRETfloxEGFP/⫹:Nav1.8Cre/⫹) or others obtained
in crosses to produce Ret-Nav1.8 CKO mice (i.e., Ret⫹/⫺:Nav1.8Cre/⫹,
Ret⫹/⫹:Nav1.8Cre/⫹, RetRETfloxEGFP/⫹:Nav1.8⫹/ ⫹, etc.). We did not observe any significant difference between Ret-Nav1.8 Het mice (RetRETfloxEGFP/⫹:
Nav1.8Cre/⫹) and these other control mice in behavior tests; therefore,
they were combined into a single group and are referred to as control
mice. To assess general health, mice were weighed and internal and surface body temperature was recorded. The experimenter was blind to the
genotypes of the mice during data acquisition. Before testing, mice were
placed in open bottom Plexiglas boxes (5 ⫻ 5 ⫻ 10 inches) on an elevated
plastic (formalin), wire mesh (von Frey, acetone), or warmed (30°C)
glass (Hargreaves) platform for 1 h (formalin, acetone) or 2–3 h (von
Frey, Hargreaves).
Formalin test. Mice were given a subcutaneous injection of 10 l of
2.5% formaldehyde into the plantar surface of the right paw, and spontaneous pain behavior was recorded in 5 min bins for a total of 1 h.
Spontaneous pain behavior included shaking, flinching, or licking of the
paw as well as holding the paw in an elevated position.
Mechanical sensitivity. Mechanical sensitivity was determined using
the von Frey test. Beginning with the smallest filament and continuing
from smallest to largest calibrated von Frey filaments were pressed to the
plantar surface of the hindpaw until the filament just bent. The withdrawal threshold is defined as the force that produces a withdrawal response in 3 of 5 consecutive applications within one trial. The threshold
was determined in 3 trials per hindpaw with a 15 min interval between
trials. Tail mechanical sensitivity was measured with an Analgesia-Meter
(Ugo Basile; Stoelting) using a modification of the Randall–Selitto test as
previously described (Morales and Gereau, 2009). The withdrawal
threshold was obtained by averaging the values obtained in 3 trials, which
were separated by 15 min.
Noxious heat sensitivity (Hargreaves test). The thermal threshold was
determined by measuring the withdrawal latency to a radiant heat source
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applied to the plantar surface of the hindpaw in 5 separate trials for each
hindpaw with a 15 min interval between trials. The withdrawal threshold
was determined by averaging the withdrawal latency obtained in each of
the trials.
Cold sensitivity. Sensitivity to a cold stimulus was measured using the
acetone test. One drop of acetone was applied to the plantar surface of the
hindpaw using a 1 ml syringe. Mice were observed for 5 min after each
acetone application. Spontaneous pain behavior (defined as above in the
formalin test) that occurred within 5 min after acetone application was
counted as a positive response. Spontaneous pain behavior that occurred
within the first 15 s after acetone application was not counted, since most
mice had some reaction to the initial application. In addition, the
amount of time spent in pain behavior was recorded. Five trials were
performed on each hindpaw with a 5 min interval between trials.
Thermal preference (gradient). Mice were tested in a thermal gradient
apparatus with zone temperatures ranging from 9°C to 51°C as described
previously (Dhaka et al., 2007). The temperature zone in which mice
spend the most time during the 2 h test is defined as the “preferred
temperature.”
Gross motor function (rotarod). An accelerating rotarod (Ugo Basile)
was used to evaluate motor coordination and balance. Five consecutive
acceleration trials were performed with a 5 min interval between trials as
described previously (Montana et al., 2009).
Sensorimotor battery. Tests in the sensorimotor battery were used as
previously described to evaluate balance, strength, coordination, and
movement (Jain et al., 2006).
Locomotor activity (open field). Locomotor activity was measured in
an open field using a VersaMax Animal Activity Monitoring System
(AccuScan Instruments). Mice were habituated to the test room in their
cages for 1 h before testing. Locomotor activity was assessed by recording
photobeam breaks in a 42 L ⫻ 42 W ⫻ 30 H cm chamber for 60 min.
Total distance traveled, time spent moving, and the number of beam
breaks (horizontal activity) were calculated for the entire chamber.
Total L4 DRG neuron counts. Mice were deeply anesthetized and perfused with PBS followed by 4% paraformaldehyde in PBS. L4 DRGs were
removed, rinsed in PBS, and embedded in paraffin. The entire DRG was
sectioned at 8 m in the transverse plane, collected in sequence, and
stained with 0.25% cresyl violet. DRG neurons containing one or more
nucleoli were counted in every 10th section. The number of neurons
counted was multiplied by 10 to obtain the total number. Counts were
corrected for split nuclei (Silos-Santiago et al., 1995).
Immunohistochemistry. To take advantage of the EGFP reporter as a
marker for neurons in which Ret is deleted, Ret-Nav1.8 CKO mice and
Ret-Nav1.8 Het control mice, each of which contain one floxed Ret allele
followed by the EGFP reporter and one Cre allele in the Nav1.8 locus,
were used in immunohistochemistry (IHC) experiments. Foot pad skin
was removed from the plantar surface of the hindpaw, immersion fixed
in Zamboni’s fixative for 2 h, rinsed in PBS, and cryoprotected in 30%
sucrose. Mice were then perfused as described above. DRG and the lumbar enlargement of the spinal cord were removed, rinsed in PBS, and
cryoprotected in 30% sucrose. Skin was sectioned at 30 m in a plane
perpendicular to the skin surface. Transverse sections of lumbar spinal
cord and DRG (30 and 18 m, respectively) were cut on a cryostat and
collected on slides. The following antibodies were used: rabbit anti-Ret
1:200 (IBL), rabbit anti-GFP 1:1000 (Invitrogen), rabbit anti TrkA 1:300
(Millipore), rabbit anti-␤III tubulin (Covance), goat anti-GFR␣2 and
GFR␣3 (1:200 and 1:50, respectively R&D Systems), and goat anti-CGRP
1:400 (Serotec). Alexa conjugated to IB4 (1:100) (Invitrogen) was used
for IB4 labeling.
Neuron counts in fluorescence-labeled DRG. To determine the percentage of labeled neurons relative to the number of EGFP-positive neurons,
labeled profiles and EGFP-positive profiles were counted in at least 3
randomly selected sections (separated by ⬎50 m) per DRG. To determine the total number of EGFP-, ␤III tubulin-, or TrkA-positive neurons, 18 m sections of the entire DRG were collected in series. Neurons
were counted in every fourth section, and the number of neurons was
multiplied by 4 to obtain the total number.
Epidermal innervation density. The dermal– epidermal border was
traced and the length determined using MetaMorph software. Labeled
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Figure 1. The conditional Ret allele is deleted with high efficiency and specificity in nonpeptidergic nociceptors by Cre expressed from the Nav1.8 locus. A, C, D, Transverse sections of spinal cord
and DRG from PND 0 mice showing EGFP expression restricted to the DRG (A) and to afferents in the superficial laminae of the dorsal horn (C) and no EGFP in motor neurons (D) in the Ret-Nav1.8 Het
mouse. B, E, F, EGFP expression in DRG neurons (B), motor neurons in the ventral horn (F ), and cell bodies in the dorsal horn (E) of the Ret EGFP/⫹ reporter mouse. G–I, PND 1 DRG from a Ret-Nav1.8
Het mouse showing virtually complete overlap of EGFP expression (G) with IB4 label (H ). Images in G–I are representative of 3 mice. Scale bars: A, B, 100 m; G–I, 30 m.
nerve fibers in the epidermis were counted and the fiber density (# of
fibers/unit of dermal– epidermal border) was calculated (Lindfors et al.,
2006).
TMP histochemistry. Frozen spinal cord sections (30 m) were incubated for 30 min at room temperature in Tris maleate buffer containing
0.08% lead nitrate and 0.25% thiamine monophosphate chloride
(Sigma) and developed in a 1% aqueous solution of sodium sulfide (Akkina et al., 2001).
Microscopy. All images were captured using an upright microscope
equipped for epifluorescence microscopy (Nikon 80i; CoolSnapES camera) and were processed using MetaMorph or Adobe Photoshop software
using global adjustments in brightness and contrast.
Quantitative real-time PCR. RNA was purified from lumbar DRG
from adult Ret-Nav1.8 CKO and control mice. RNA (1 g) was reverse
transcribed using M-MLV Reverse Transcriptase (Invitrogen). Quantitative real-time PCR (qRT-PCR) was performed using Fast SYBR Green
Master Mix (Applied Biosystems), and reactions were run in an Applied
Biosystems 7900HT Real Time Thermal Cycler. All reactions were run in
triplicate, and relative fold changes in RNA amount were calculated by
the ⌬⌬CT method using GAPDH to normalize samples (Livak and
Schmittgen, 2001).
Real-time PCR (qRT-PCR) primer sequences are as follows (5⬘33⬘):
RET: F, ACACCTTCGGACTCACTGCT; R, CAGGGGTGTCTCCTCTTCTG; GAPDH: F, TGCCCCCATGTTTGTGATG; R, TGTGGTCATGAGCCCTTCC; prostatic acid phosphatase (PAP): F, CTCGAAATATACCTGAGTCCATGCT; R, TGGGAGCTTGAATGTCTACGTTTT.
The TRPA1 primer sequence has been previously described by Elitt et al.
(2006), and the TRPM8 and TRPV1 primer sequences have been previously described by Albers et al. (2006).
Statistical analysis. Data are reported as the mean ⫾ SEM. Statistically
significant differences were determined using the Student’s t test.

Results
Specific and efficient conditional deletion of Ret in
nonpeptidergic nociceptors
Tissue-specific conditional deletion of genes is a powerful strategy to study the function of genes whose embryological loss results in lethality. Ret loss results in perinatal death due to renal
agenesis (Schuchardt et al., 1994). We reasoned that generating
mice expressing a conditional RET allele (RETfloxEGFP) and the
nociceptor-specific Nav1.8 Cre would allow us to study the function of Ret specifically in these neurons. We first determined
whether Cre expressed from the Nav1.8 locus could delete the
conditional RET allele in an efficient and specific manner. We
generated compound heterozygous mice that harbor one RET
conditional allele and one Nav1.8 Cre allele (RetRETfloxEGFP/⫹:
Nav1.8Cre/⫹, “⫹” denotes the endogenous wild-type mouse allele). This strategy allows simultaneous visualization of the
excised allele by direct detection of EGFP signal and fluorescencelabeled markers (including Ret) for nonpeptidergic nociceptors
(Jain et al., 2006). In spinal cord and DRG from RetRETfloxEGFP/⫹:
Nav1.8Cre/⫹ postnatal day (PND) 1 mice, EGFP signal is restricted
to DRG neurons and to afferents in the superficial lamina of the
dorsal horn where small-diameter DRG neurons terminate, suggesting specific deletion of Ret in nonpeptidergic nociceptors
(Fig. 1 A, C,D). EGFP is not detected in motor neurons in the
ventral horn of the spinal cord or in sympathetic ganglia in these
mice, sites where Ret is known to be expressed, as shown by EGFP
signal in Ret-EGFP reporter mice that express EGFP in all Retpositive cells (Fig. 1 A–F and data not shown). In addition, we
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observed EGFP expression in spinal
dorsal horn neurons in Ret-EGFP reporter mice (Fig. 1 B, E) that is absent in
Ret-Nav1.8 CKO mice (Fig. 1 A, C).
These results suggest specific deletion
of the RET conditional allele in smalldiameter nociceptors.
We determined the efficiency of conditional Ret deletion in small-diameter
DRG neurons using IB4 labeling, which
overlaps virtually completely with Ret in
small-diameter nonpeptidergic DRG neurons (Molliver et al., 1997; Bennett et al.,
1998b). IB4 labeling in lumbar DRG from
PND 1 Ret-Nav1.8 Het mice (RetRETfloxEGFP/⫹:
Nav1.8Cre/⫹) reveals specific and efficient
deletion of Ret in IB4-labeled neurons
(Fig. 1G–I ). Of 560 neurons expressing
EGFP (neurons from which Ret is deleted
allowing expression of the EGFP reporter
from the Ret locus), 557 were labeled with
IB4, indicating ⬎99% specificity of Ret
deletion in the IB4 binding population
(n ⫽ 3). Of 603 IB4-positive neurons, 562
express EGFP, indicating that Ret is excised from 93% of IB4-positive DRG neurons (n ⫽ 3). These results indicate that
Ret is deleted with high efficiency and
specificity in the population of smalldiameter DRG neurons that bind IB4
Figure 2. Ret expression is not detected in small-diameter DRG neurons in Ret-Nav1.8 CKO mice. A, B, DRG from a PND 60 WT
(nonpeptidergic nociceptors).
We next generated Ret-Nav1.8 CKO mouse (A) and a Ret-Nav1.8 CKO mouse (B) labeled with an anti-Ret antibody showing loss of Ret exclusively in small-diameter DRG
neurons in the Ret-Nav1.8 CKO mouse (B). Photographs are representative of the staining pattern observed in three mice of each
mice (RetRETfloxEGFP/⫺:Nav1.8Cre/⫹). Ret- genotype. C–E, DRG from
a PND 10 Ret-Na 1.8 CKO mouse showing no overlap of EGFP (C) with anti-Ret antibody (D). Merged
Nav1.8 CKO mice were viable, grew nor- image of C and D is shown in E. There arev two cells in E in which EGFP and Ret appear to overlap. The cell on the right is a
mally to adulthood, and were grossly large-diameter Ret-positive neuron with an EGFP-positive neuron on top of it. It can be seen that EGFP is not present in the same
indistinguishable from control littermates cell, since the EGFP label fills a smaller area than the Ret label. In addition, the cells are not in the same plane of focus. The cell on
that harbor at least one functional Ret al- the left is not EGFP positive, but exhibits autofluorescence, which is clearly different from the very bright EGFP labeling seen in the
lele in nonpeptidergic nociceptors. There cell immediately to the left. Scale bars: (in B) A, B, 20 m; (in E) C–E, 30 m.
was no difference in adult body weight or
in internal or surface body temperature between Ret-Nav1.8 CKO
Table 1. Relative changes in gene expression determined by qRT-PCR
and control mice, consistent with equivalent general health of the
Gene
Ret CKO mice (% of control)
two groups (data not shown).
Ret
1%**
To confirm that Ret is deleted from small-diameter DRG neuPAP
47%*
rons (nociceptors), lumbar DRGs from adult Ret-Nav1.8 CKO
TRPV1
113%
and WT mice were labeled with antibodies to Ret (Fig. 2 A, B). In
TRPA1
54%
WT DRG, Ret is observed in both large- and small-diameter DRG
TRPM8
154%*
neurons (Fig. 2 A). In Ret-Nav1.8 CKO mice, Ret labeling is abn ⫽ 3 Ret-Nav1.8 CKO mice and 5 control mice. *p ⬍ 0.05; **p ⬍ 0.001.
sent in small-diameter neurons but remains in large-diameter
neurons (Fig. 2 B). Ret labeling in DRG from PND 10 Ret-Nav1.8
CKO mice shows no overlap between EGFP signal (neurons in
trophic support of nociceptors, we compared the total number of
which Ret is deleted) and Ret immunoreactivity, indicating speL4 DRG neurons in adult Ret-Nav1.8 CKO mice and control
mice. We found a 33% decrease in the total number of L4 DRG
cific deletion of Ret from nonpeptidergic nociceptors (Fig. 2C–
neurons in Ret-Nav1.8 CKO mice compared to control mice (Fig.
E). As expected, qRT-PCR shows a significant decrease in Ret
3A–C). Because small-diameter nonpeptidergic nociceptors are a
expression in lumbar DRG from Ret-Nav1.8 CKO mice compared to control mice (Table 1).
subset of total DRG neurons, we investigated the extent of neuron
loss in the EGFP-positive subpopulation of DRG neurons by
Ret regulates nociceptor survival and size
counting the total number of EGFP-positive cells. There is a 52%
While GFLs promote survival and provide trophic support to
decrease in the number of EGFP-positive L4 DRG neurons in
many types of neurons, the physiological role of Ret in small
Ret-Nav1.8 CKO mice compared to Ret-Nav1.8 Het control mice
(Fig. 3D–F ).
nociceptive DRG neurons has not been examined in adult aniTo determine whether neuron loss in the population of EGFPmals and remains unclear. Studies in GFL- and Gfr␣ coreceptornull mice have reported variable results (Airaksinen and Saarma,
positive neurons accounts for the cell loss observed in total
2002). To determine whether Ret is required for survival and
neuron counts (33% above), we counted EGFP- and ␤III
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D
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H

Average soma area (μm²)

Number of EGFP-positive neurons

F

Soma Area (μm²)

K
Percent of Neurons

I

16
12

**

**
Control
Ret CKO

therefore correspond to a ⬃24% decrease
in total neuron number, accounting for
most if not all of the DRG neuron loss in
Ret-Nav1.8 CKO mice.
The soma size of DRG neurons is influenced by the expression of GFL ligands
and GFL coreceptors (Zwick et al., 2002;
Elitt et al., 2006; Lindfors et al., 2006). We
compared the soma area of EGFP-positive
DRG neurons in Ret-Nav1.8 CKO and
Ret-Nav1.8 Het control mice to determine
whether Ret signaling is required for trophic support of nonpeptidergic nociceptors. We found a 39% decrease in the
soma area of EGFP-positive DRG neurons
in adult Ret-Nav1.8 CKO mice compared
to Ret-Nav1.8 Het control mice (Fig.
3D,E,G). Size frequency analysis of EGFPpositive neurons suggests that size is decreased across the entire population of
EGFP-positive neurons (Fig. 3H ). These
results indicate that Ret signaling is required for trophic maintenance of mature
nonpeptidergic DRG neurons and is in
agreement with findings in adult Gfr␣2null and PND 14 Ret-Wnt1 CKO mice
(Lindfors et al., 2006; Luo et al., 2007).

Ret regulates expression of Gfr␣3 in
nonpeptidergic nociceptors
EGFP
In the DRG, Gfr␣2 and Gfr␣3 expression
J
GFRα3
is largely restricted to small-diameter neu4
rons, while Gfr␣1 is expressed in both
large-diameter and small-diameter DRG
0
GFRα3+/EGFP+ EGFP+/GFRα3+
neurons (Bennett et al., 1998b; Orozco et
al., 2001; Stucky et al., 2002; Lindfors et
Ret CKO
al., 2006; Luo et al., 2007). Because it has
Figure 3. The number and size of nonpeptidergic nociceptors is decreased in Ret-Nav1.8 CKO mice. A–C, The total number of been reported that Gfr␣2 deletion alters
neurons is decreased in the L4 DRG of adult Ret-Nav1.8 CKO mice (B, C; n ⫽ 4) compared to control mice (A, C; n ⫽ 8) (*p ⬍ 0.05). sensory function (Stucky et al., 2002;
D–F, The number of EGFP-positive DRG neurons is decreased in L4 DRG of Ret-Nav1.8 CKO mice (E, F ) compared to Ret-Nav1.8 Het Lindfors et al., 2006) and Ret alters Gfr␣2
control mice (D, F ) (F, n ⫽ 3 of each; *p ⫽ 0.01). D, E, G, H, The soma area of EGFP-positive DRG neurons is decreased in Ret-Nav1.8
expression (Luo et al., 2007), we examCKO mice (E) compared to Ret-Nav1.8 Het control mice (D) (G, n ⫽ 3 of each; *p ⬍ 0.05). H, Size frequency analysis of EGFPined Gfr␣2 expression in Ret-Nav1.8 CKO
positive neurons. I–K, EGFP (Ret) and GFR␣3 do not overlap extensively in lumbar DRG of Ret-Nav1.8 Het control mice (I ). Overlap
of EGFP and GFR␣3 is also not extensive in Ret-Nav1.8 CKO mice (J ) but is significantly increased compared to Ret-Nav1.8 Het mice. We also examined expression of
control mice (K, n ⫽ 4 Ret-Nav1.8 CKO mice, n ⫽ 5 control mice, **p ⬍ 0.01). In C, F, G, and K, data are represented as mean ⫾ Gfr␣3, the other Gfr␣ coreceptor expressed
exclusively in small-diameter DRG neurons
SEM. Scale bars: (in E) D, E, 30 m; (in J) I, J, 50 m.
(Orozco et al., 2001; Elitt et al., 2006). In
agreement with previous reports (Bennett
Table 2. Percent of lumbar DRG neurons in which EGFP is colocalized with other
et
al.,
1998b;
Lindfors
et
al., 2006; Luo et al., 2007), we found that
markers (mean ⴞ SEM)
␣
2-positive
neurons in Ret-Nav1.8 Het control
virtually
all
Gfr
EGFP-positive neurons
Other marker neurons
mice are also EGFP positive (express Ret) and the majority of
expressing other marker
expressing EGFP
EGFP-positive neurons coexpress Gfr␣2 (Table 2). Deletion of
Marker
Ret CKO
Control
Ret CKO
Control
Ret had no effect on the percentage of EGFP-positive neurons
␤III Tubulin
nd
nd
32 ⫾ 2.1**
46.7 ⫾ 2.5
that coexpress Gfr␣2, suggesting that Gfr␣2 expression is not
TrkA
25 ⫾ 5.8*
9.3 ⫾ 2.2
22.1 ⫾ 4.3*
10 ⫾ 2.6
regulated by Ret in nonpeptidergic nociceptors (Table 2). The
67.7 ⫾ 0.6
72.9 ⫾ 4.5
71.7 ⫾ 1.5***
94.2 ⫾ 1.1
GFR␣2
percentage of Gfr␣2-positive neurons that express EGFP is sigGFR␣3
14.3 ⫾ 1.1**
6.6 ⫾ 1.3
13.5 ⫾ 1.9**
6.0 ⫾ 0.9
nificantly less in Ret-Nav1.8 CKO mice than in Ret-Nav1.8 Het
n ⫽ 3 of each genotype for ␤III tubulin and Gfr␣2, and 4 of each genotype for TrkA. For Gfr␣3, n ⫽ 4 Ret-Nav1.8 CKO
control mice, likely reflecting the loss of EGFP neurons in Retmice and 5 control mice. *p ⱕ 0.05; **p ⬍ 0.01; ***p ⬍ 0.001.
Nav1.8 CKO mice. Surprisingly, we did not find extensive overlap
between EGFP (Ret) and GFR␣3 in Ret-Nav1.8 Het control mice
tubulin-positive neurons to determine the percentage of total
(Fig. 3 I, K, Table 2). This is in contrast to previous reports, which
DRG neurons that are EGFP positive (Table 2). In Ret-Nav1.8 Het
have found greater colocalization of Ret and Gfr␣3 (Orozco et al.,
mice, EGFP-positive neurons account for 46.7 ⫾ 2.5% of total
2001; Luo et al., 2007). We do not believe that our failure to detect
DRG neurons. Loss of 52% of EGFP-positive neurons would
significant coexpression of EGFP and Gfr␣3 is due to lack of
Control

8
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Nav1.8 expression in Gfr␣3-positive neurons, because Gfr␣3 is expressed exclusively in small-diameter DRG neurons
(Orozco et al., 2001; Elitt et al., 2006) and
Nav1.8 is expressed in nearly all smalldiameter DRG neurons (Stirling et al.,
2005), suggesting significant overlap of
Nav1.8 and Gfr␣3 expression. Deletion
of Ret results in an increase in the proportion of Gfr␣3-positive neurons that
are EGFP-positive (Fig. 3 J, K, Table 2),
suggesting that Ret negatively regulates
Gfr␣3 expression in small-diameter DRG
neurons.

A

EGFP

B

β III Tubulin

C

CGRP

Control

D

E

F

Ret CKO

Number of fibers/
unit length of epidermis

G
Control
8
Ret deletion decreases peripheral but
Ret CKO
not central afferent density of
nonpeptidergic nociceptors
6
To determine whether neuron loss due
to Ret deletion is accompanied by a corresponding loss of peripheral innervation,
4
we quantified the density of EGFP-positive fibers in the epidermis (Fig. 4 A, D,G).
2
Labeling with an anti-EGFP antibody was
**
required to visualize EGFP afferents in
the skin. The density of EGFP-positive
0
sensory afferents in the epidermis of
β III Tubulin
EGFP
CGRP
Ret-Nav1.8 CKO mice is significantly decreased compared with Ret-Nav1.8 Het
control mice. This decrease in nonpepti- Figure 4. The density of nonpeptidergic fibers is decreased in the epidermis of Ret-Nav1.8 CKO mice. The density of EGFPdergic afferents in the epidermis likely re- positive fibers (A, D, G) in the epidermis is significantly decreased in Ret-Nav1.8 CKO mice (D) compared to Ret-Nav1.8 Het control
flects the loss of nonpeptidergic neurons. mice (A) (n ⫽ 4 for each genotype, **p ⬍ 0.005). Total epidermal innervation, as measured by the density of ␤III tubulin-positive
Surprisingly, the total epidermal fiber fibers (B, E, G), is not different in Ret-Nav1.8 CKO mice (E) from that in Ret-Nav1.8 Het controls (B) (n ⫽ 8 for each genotype). The
density of CGRP-positive fibers (C, F, G) is also not different in Ret-Nav1.8 CKO mice (F ) from that in Ret-Nav1.8 Het control mice (C)
density, as determined by the density of (n ⫽ 7 for each genotype). In G, data are represented as mean ⫾ SEM.
Scale bar: (in F) A–F, 50 m.
␤III tubulin-positive fibers, is not significantly different in Ret-Nav1.8 CKO mice
lution of the GFP antibody, suggesting that oversaturation of the
from that in Ret-Nav1.8 Het control mice (Fig. 4 B, E,G). The
fluorescent signal did not obscure loss of EGFP-positive afferents
majority of nerve fibers in the epidermis are from nonpeptidergic
(data not shown). IB4 labeling of nonpeptidergic afferents in the
DRG neurons that express Ret or from DRG neurons that express
lumbar dorsal horn was also similar in Ret-Nav1.8 CKO mice and
the NGF receptor TrkA and coexpress neuropeptides (Zylka et
Ret-Nav1.8 Het control mice (see Fig. 8 F, G). Therefore, although
al., 2005). To determine whether expansion of the TrkA/peptithere is a significant loss of nonpeptidergic neurons in Ret-Nav1.8
dergic fiber population in the epidermis accounts for the normal
CKO mice, the density and topography of the central projections
number of ␤III tubulin-labeled fibers observed in Ret-Nav1.8
of these neurons in the dorsal horn appear normal. Ret signaling
CKO mice, we compared the density of CGRP-positive fibers in
is therefore dispensable for the development and maintenance of
Ret-Nav1.8 CKO mice and Ret-Nav1.8 Het control mice (Fig.
central projections from nonpeptidergic DRG neurons, since
4C, F, G). We found that there is no difference in the density of
surviving nonpeptidergic neurons reach their central targets in
CGRP-positive fibers in the epidermis of Ret-Nav1.8 CKO and
the absence of Ret.
control mice, indicating that expansion of peptidergic afferents
does not account for the normal density of ␤III tubulin-labeled
epidermal afferents observed in Ret-Nav1.8 CKO mice.
Ret-Nav1.8 CKO mice have normal responses to mechanical
In the spinal cord dorsal horn, TrkA (peptidergic) and Ret
stimuli and noxious heat
(nonpeptidergic) afferents are segregated with TrkA afferents ocTo determine whether loss of Ret in nociceptors affects mechancupying lamina I and lamina IIo and Ret afferents occupying
ical sensitivity, von Frey testing was performed on Ret-Nav1.8
lamina IIi (Molliver et al., 1997). Double labeling of EGFP (Ret)
CKO and control mice. There is no difference in hindpaw meand CGRP (TrkA) afferents in the lumbar dorsal horn shows that
chanical sensitivity between Ret-Nav1.8 CKO mice and control
mice (Fig. 6 A, left). Sensitivity to a noxious mechanical stimulus,
the non-overlapping pattern of Ret and TrkA afferents observed
determined using a modified Randall–Selitto test, is also not difin lamina I and lamina II of Ret-Nav1.8 Het control mice is indistinguishable from the pattern observed in Ret-Nav1.8 CKO mice
ferent in Ret-Nav1.8 CKO mice from that in control mice (Fig.
(Fig. 5A–F ). In addition, the density of EGFP labeling in Ret6 A, right). These results indicate that Ret signaling in nonpeptiNav1.8 CKO mice is similar to Ret-Nav1.8 Het control mice, indergic DRG neurons is not required for normal behavioral sendicating that, in contrast to peripheral projections, the density of
sitivity to innocuous or noxious mechanical stimuli. Recent
the central projections of nonpeptidergic Ret afferents is unchanged
reports demonstrating increased mechanical thresholds in mice
in the absence of Ret. Similar results were obtained with higher diin which most/all nonpeptidergic DRG neurons are killed using
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Ret-Nav1.8 CKO mice show increased
sensitivity to cold (acetone)
To determine whether Ret loss in nonpeptidergic nociceptors influences sensitivity
to a cold stimulus, we assessed cold sensitivity in Ret-Nav1.8 CKO mice and control mice using the acetone test. Female
Ret-Nav1.8 CKO mice respond to a significantly greater percentage of acetone applications than female control mice (Fig.
Ret CKO
Control
6C). In addition, the total amount of time
spent in pain-like behavior is significantly
CGRP
C
D
greater for female Ret-Nav1.8 CKO mice
than for female controls (Fig. 6 D). In contrast, male Ret-Nav1.8 CKO mice are not
different from male control mice (Fig.
6C,D). This result suggests that disruption
of Ret signaling in nonpeptidergic DRG
neurons in female Ret-Nav1.8 CKO mice
results in greater sensitivity to cold and is
consistent with the observation that a
mixed group of male and female Gfr␣2Merge
null mice show increased sensitivity to
E
F
cold (Lindfors et al., 2006). In addition,
our findings suggest that cold sensitivity
may be influenced by gender. This possibility is consistent with a recent report of
gender-based differences in cold sensitivity in TRPA1-null mice (Kwan et al.,
2006).
Our results suggest that Ret signaling
in nonpeptidergic nociceptors regulates
cold sensation. Alternatively, loss of nonFigure 5. The density and topography of the central projections of nonpeptidergic nociceptors appear normal in Ret-Nav1.8 CKO
peptidergic neurons could contribute to
mice. The density and topography of the central projections from nonpeptidergic DRG neurons in the superficial laminae of the
lumbar dorsal horn of Ret-Nav1.8 CKO mice (A, C, E) are not changed compared with Ret-Nav1.8 Het control mice (B, D, F ). Photos increased cold sensitivity in Ret-Nav1.8
CKO mice. However, this possibility is inare representative of four mice of each genotype. Scale bar: (in F) A–F, 50 m.
consistent with recent reports in which
diphtheria toxin (DTA) suggest that nonpeptidergic nociceptors
DTA is used to kill specific subpopulations of DRG neurons and
are required for normal mechanical sensitivity (Abrahamsen et
cold sensitivity is either abolished or unchanged (Abrahamsen et
al., 2008; Cavanaugh et al., 2009). In Ret-Nav1.8 CKO mice in
al., 2008; Cavanaugh et al., 2009). Examination of the expression
which ⬃50% of nonpeptidergic DRG neurons are lost, we obof the cold-activated channels TRPA1 and TRPM8 in Ret-Nav1.8
CKO by qRT-PCR reveals a significant increase only in TRPM8
served no change in mechanical sensitivity, indicating that 50%
expression in Ret-Nav1.8 CKO mice compared to control mice
or less of the normal number of non-peptidergic DRG neurons is
(Table 1). This result suggests that Ret signaling normally supsufficient to maintain normal mechanical sensitivity.
presses the expression of TRPM8 and that the mechanism underPrevious studies suggest that GFL/Ret signaling may modulying increased cold sensitivity in Ret-Nav1.8 CKO mice may
late noxious heat transduction in IB4 nociceptors (Stucky et al.,
involve TRPM8. Previous reports indicating that TRPM8 is not
2002; Lindfors et al., 2006). We found that noxious heat sensitivcolocalized with Nav1.8 (Abrahamsen et al., 2008) or IB4 (Dhaka
ity, as measured by the Hargreaves test, is not different between
et al., 2008) suggest that TRPM8 and Ret are not colocalized and
Ret-Nav1.8 CKO and control mice (9.2 ⫾ 0.5 s, 8.8 ⫾ 0.3 s,
respectively; p ⫽ 0.4; Ret-Nav1.8 CKO, n ⫽ 25, control, n ⫽ 55).
may indicate that modulation of TRPM8 expression by Ret is
Consistent with this finding, qRT-PCR analysis reveals no change
indirect.
in the expression of the noxious heat-activated channel TRPV1 in
Ret-Nav1.8 CKO mice compared to control mice (Table 1). BeRet-Nav1.8 CKO mice exhibit increased pain behavior in the
cause male and female mice respond differently to noxious therformalin test
mal stimuli (Mogil et al., 2000), we analyzed data from male and
We performed the formalin test in Ret-Nav1.8 CKO and control
mice to determine whether deletion of Ret in small-diameter
female mice separately. There was no difference between RetDRG neurons affects spontaneous pain behavior induced by inNav1.8 CKO and control mice in the male or female group (Fig.
6 B). As previously reported, male control mice had significantly
flammation. Ret-Nav1.8 CKO mice have an increased response,
compared to control mice, in both phases of the formalin test
longer withdrawal latencies than female control mice (Mogil et
(Fig. 7). In the first phase of the formalin test, Ret-Nav1.8 CKO
al., 2000). Thermal preference, measured using a thermal gradimice spent 25% more time engaged in spontaneous pain behavent apparatus, was not different in male or female Ret-Nav1.8
CKO from that in control mice (supplemental Fig. S1, available at
ior than control mice. In the second phase, Ret-Nav1.8 CKO mice
www.jneurosci.org as supplemental material).
spent ⬃40% more time engaged in spontaneous pain behavior

A

B

GFP
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Sensorimotor and motor function is
not altered in Ret-Nav1.8 CKO mice
To ensure that behavioral changes observed in Ret-Nav1.8 CKO are sensory
specific and are not related to disturbances of general sensorimotor function or to motor deficits, we performed
sensorimotor testing in Ret-Nav1.8 CKO
mice and control mice. The performance
of Ret-Nav1.8 CKO mice is not different
from Ret control mice in any of these
tests (supplemental Figs. S1, S2, available
at www.jneurosci.org as supplemental
material).
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than control mice. These data suggest that
Ret signaling in nociceptors attenuates
formalin-induced inflammatory pain.
Our results are contrary to the decreased formalin-induced pain behavior
observed in Gfr␣2-null mice. Although
decreased cell size suggests Ret signaling is
decreased in Gfr␣2-null mice (Lindfors et
al., 2006), it is not known to what extent
Ret signaling is impaired in Gfr␣2-null
mice, since many sensory neurons express more than one Gfr␣ coreceptor.
In addition, Ret-Nav1.8 CKO mice exhibit cell loss and changes in peripheral
innervation, which are different from
anatomical changes observed in Gfr␣2null mice. Gfr␣2-null mice also are reported to be severely growth retarded,
which could influence pain behavior.
Therefore, it is not surprising that the
phenotypes of these two mutant mice
are not identical.
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Figure 6. Ret-Nav1.8 CKO mice have normal responses to mechanical and noxious heat stimuli but are hypersensitive to a cold
stimulus. A, Mechanical sensitivity is not changed in Ret-Nav1.8 CKO mice compared to control mice. Left, von Frey, Ret-Nav1.8 CKO
mice, n ⫽ 10; control mice n ⫽ 17. Right, Randall–Selitto, n ⫽ 14 of each genotype. B, Noxious heat sensitivity is unchanged in
female and male Ret-Nav1.8 CKO mice compared with female and male control mice (females: Ret-Nav1.8 CKO mice, n ⫽ 11;
control, n ⫽ 38; males: Ret-Nav1.8 CKO mice, n ⫽ 8; control, n ⫽ 17). Female Ret-Nav1.8 CKO and control mice have a significantly
shorter withdrawal latency than male Ret-Nav1.8 CKO and control mice (female vs male Ret-Nav1.8 CKO mice, p ⬍ 0.05; female vs
male control, p ⬍ 0.000001). C, D, Female Ret-Nav1.8 CKO mice are hyper-responsive to acetone compared to female control mice.
C, Female Ret-Nav1.8 CKO mice (n ⫽ 11) respond to a significantly greater percentage of acetone applications than female control
mice (n ⫽ 24) (**p ⬍ 0.001). Male Ret-Nav1.8 CKO mice (n ⫽ 10) are not different from male controls (n ⫽ 18) in percentage of
responses to acetone applications. Female control mice (n ⫽ 24) respond to a significantly lower percentage of acetone applications than male control mice (n ⫽ 18) (*p ⬍ 0.05). D, Female Ret-Nav1.8 CKO mice (n ⫽ 7) spend significantly more time engaged
in pain behavior than female control mice (n ⫽ 11) following acetone application (*p ⫽ 0.05). Male Ret-Nav1.8 CKO mice (n ⫽ 4)
are not different from male control mice (n ⫽ 9) in the amount of time spent in pain behavior. Female control mice (n ⫽ 11) are
not different from male control mice (n ⫽ 9) in the amount of time spent in pain behavior. Data are represented as mean ⫾ SEM.

TrkA expression is not increased in Ret-Nav1.8 CKO mice
NGF is a well established mediator of inflammation and attenuation of NGF/TrkA signaling decreases inflammation-induced
pain behavior in the formalin test (Pezet and McMahon, 2006;
Ugolini et al., 2007). Expanded TrkA expression could therefore
explain the enhanced response to formalin observed in RetNav1.8 CKO mice. We examined TrkA expression in sensory
neurons from which Ret is deleted to determine whether TrkA
expression is expanded in this population. In control mice, we
found that TrkA is coexpressed in 9.3 ⫾ 2.2% of DRG neurons
that express Ret (EGFP-positive neurons), consistent with previous reports (Table 2) (Molliver et al., 1997). There is an increase
in the percentage of EGFP-positive neurons that coexpress TrkA
in Ret-Nav1.8 CKO mice compared with Ret-Nav1.8 Het control
mice (Fig. 8 A–C, left, Table 2). The increase in TrkA coexpression in EGFP-positive neurons could be a result of expansion of
TrkA expression in the nonpeptidergic population of nociceptors
or may reflect the decreased number of EGFP-positive neurons in
Ret-Nav1.8 CKO mice. Quantification of the total number of
TrkA-positive neurons in lumbar DRG revealed that the total
number of TrkA-positive neurons is not different in Ret-Nav1.8
CKO mice from that in Ret-Nav1.8 Het control mice (Fig. 8C,
right). Although the total number of TrkA-positive DRG neurons
is not significantly altered in Ret-Nav1.8 CKO, the proportion of
TrkA-positive nociceptors is increased due to loss of nonpepti-

dergic nociceptors in Ret-Nav1.8 CKO mice. An increase in the
proportion of “proinflammatory” TrkA nociceptors may contribute to increased inflammation-induced pain observed in RetNav1.8 CKO mice.
Reduced TMP activity in Ret-Nav1.8 CKO mice
TMP is a well known marker for nonpeptidergic DRG neurons
and is known to colocalize extensively with IB4 (Bennett et al.,
1998b; Zylka et al., 2008). A recent report has identified TMP as
the transmembrane form of PAP, an enzyme that dephosphorylates extracellular AMP to produce the analgesic molecule adenosine (Zylka et al., 2008). PAP-null mice show normal sensitivity
to mechanical and noxious thermal stimuli but are hypersensitive
in chronic inflammatory and neuropathic pain models. The expression of PAP specifically in nonpeptidergic DRG neurons and
the similar behavior phenotypes of PAP-null mice and RetNav1.8 CKO mice suggested the possibility that Ret signaling
might influence PAP expression or activity. We performed TMP
histochemistry and found that TMP staining is greatly reduced in
the superficial laminae of the lumbar dorsal horn of Ret-Nav1.8
CKO mice compared with Ret-Nav1.8 Het control mice, suggesting that Ret modulates TMP expression and/or activity (Fig.
8 D, E). Since the central projections of nonpeptidergic DRG neurons are apparently normal in Ret-Nav1.8 CKO mice as shown by
EGFP (Fig. 5) and IB4 labeling (Fig. 8 F, G), it is unlikely that the
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Figure 7. Ret-Nav1.8 CKO mice exhibit increased formalin-induced pain behavior. RetNav1.8 CKO (n ⫽ 9) mice show increased sensitivity to formalin compared to control mice (n ⫽
11). A, Time course of spontaneous pain behavior following intraplantar injection of formalin. B,
Total time spent in spontaneous pain behavior in phase 1 (5–10 min) and phase 2 (10 – 60 min)
of the formalin test. Ret-Nav1.8 CKO mice are different from control mice in both phases (phase
1, **p ⬍ 0.01; phase 2, *p ⬍ 0.05). Data are represented as mean ⫾ SEM.

decrease in TMP staining is due to loss of nonpeptidergic afferents in the dorsal horn. Using qRT-PCR, we found that PAP
expression is significantly decreased in lumbar DRG from RetNav1.8 CKO mice compared to control mice (Table 1). These
results are consistent with the possibility that Ret positively regulates PAP expression and/or activity and that loss of Ret in nonpeptidergic nociceptors results in a decrease in PAP with a
consequent increase in formalin-induced pain.

Discussion
Specific deletion of Ret in nonpeptidergic nociceptors of RetNav1.8 CKO mice has, for the first time, provided an opportunity
to examine the physiological function of GFL/Ret signaling in
nonpeptidergic nociceptors in mature mice. Our results demonstrate that Ret is required for the survival, trophic support, and
normal function of nonpeptidergic nociceptors and provide evidence that decreased PAP expression or activity may be the molecular mechanism underlying increased formalin-induced pain
following Ret deletion in nociceptors.
Ret signaling is required for survival of
nonpeptidergic nociceptors
Ret expression increases from embryonic day 17 to PND 7 in
maturing nonpeptidergic DRG neurons, while TrkA expression

Control

IB4

Ret CKO

Figure 8. The number of TrkA-positive neurons is unchanged in lumbar DRG from Ret-Nav1.8
CKO and TMP (PAP) expression is decreased in the dorsal horn of the spinal cord of Ret-Nav1.8
CKO mice. The percentage of EGFP-positive neurons that coexpress TrkA is increased in RetNav1.8 CKO mice (B, C, left) compared with Ret-Nav1.8 Het control mice (A, C, left) (*p ⬍ 0.05,
n ⫽ 4 of each genotype). Arrows indicate EGFP/TrkA double-labeled neurons. C, Right,
The total number of TrkA-positive neurons is not different in Ret-Nav1.8 CKO mice from that in
Ret-Nav1.8 Het control mice (n ⫽ 4 of each genotype). D, E, TMP (PAP) is decreased in the
superficial laminae of the dorsal horn of the spinal cord in Ret-Nav1.8 CKO mice (E) compared
with Ret-Nav1.8 Het control mice (D). IB4 labeling is the same in Ret-Nav1.8 Het control (F ) and
Ret-Nav1.8 CKO mice (G). Images shown in D and E are representative of eight mice of each
genotype, F and G are representative of 6 mice of each genotype. In C, data are represented as
mean ⫾ SEM. Scale bars: B (for A, B), G (for D–G), 50 m.

is extinguished between PND 0 and PND 21 (Molliver et al.,
1997). A recent study in which Ret was conditionally deleted in
DRG neurons using Wnt1-Cre reported that Ret is required for
TrkA extinction in nonpeptidergic neurons (Luo et al., 2007). In
contrast, we found that TrkA expression is not maintained in
nonpeptidergic neurons in adult Ret-Nav1.8 CKO mice. Although the rate of TrkA extinction is decreased in Ret-Wnt1 CKO
mice, TrkA expression is significantly decreased during the first
two postnatal weeks in these mice (Luo et al., 2007), suggesting
that, in agreement with our results, TrkA extinction occurs in
nonpeptidergic DRG neurons in the absence of Ret. In addition,
extinction of TrkA expression in nonpeptidergic DRG neurons is
reportedly not complete until PND 21 (Molliver et al., 1997).
Since Ret-Wnt1 CKO mice die in the third postnatal week it was
not possible to determine whether TrkA extinction continues
after P14 or whether TrkA extinction is completed in these mice.
Deletion of Ret in nonpeptidergic nociceptors in Ret-Nav1.8
CKO mice results in ⬃50% loss of these neurons. Although GFL/
Ret signaling is reported to influence sensory neuron survival
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under various experimental conditions (Matheson et al., 1997;
Airaksinen and Saarma, 2002; Zwick et al., 2002; Elitt et al., 2006),
the role of endogenous GFL/Ret signaling in sensory neuron survival in mature animals is unclear. Analysis of GFL- and GFL
coreceptor-null mice has produced inconsistent results (Airaksinen
and Saarma, 2002) due to overlapping expression of Gfr␣ coreceptors in many DRG neurons (Bennett et al., 1998b). Determination of neuron numbers in mice in which Ret is deleted has
overcome this confound, since Ret partners with all of the GFL
coreceptors.
The incomplete loss of nonpeptidergic DRG neurons in RetNav1.8 CKO mice suggests that a subpopulation of nonpeptidergic neurons is not dependent on Ret signaling for survival. DRG
neurons become increasingly independent of trophic factors for
survival during the first three postnatal weeks, the same period
during which the transition from TrkA to Ret expression occurs
in nonpeptidergic neurons (Molliver et al., 1997; Vogelbaum et
al., 1998). During the transition from TrkA to Ret expression, a
subpopulation of nonpeptidergic neurons coexpresses both receptors, raising the possibility that nonpeptidergic neurons that
downregulate TrkA late in postnatal development depend on
NGF/TrkA signaling for survival in the absence of Ret. In support
of this possibility, before TrkA extinction in nonpeptidergic DRG
neurons, NGF can support the survival of these neurons in vitro
(Molliver et al., 1997), suggesting that NGF/TrkA signaling can
substitute for GFL/Ret signaling to maintain survival of nonpeptidergic neurons. Neurons that lose TrkA expression early in the
period of transition when they are still trophic factor-dependent
likely die in Ret-Nav1.8 CKO because they lack both Ret and
TrkA.
DRG neuron loss was not observed at PND 14 in Ret-Wnt1
CKO mice, suggesting that DRG neuron survival is not dependent on Ret (Luo et al., 2007). However, at P14 TrkA extinction is
not yet complete in nonpeptidergic neurons (Molliver et al.,
1997). Nonpeptidergic neurons that continue to express TrkA at
PND 14 could survive through NGF/TrkA signaling in the absence of Ret. There may be a subpopulation of DRG neurons lost
by PND14 in Ret-Wnt1 CKO mice (likely those that downregulate TrkA before PND 14) that is too small to detect.
Central and peripheral projections of nonpeptidergic DRG
neurons in Ret-Nav1.8 CKO mice
Surprisingly, the density of central projections of nonpeptidergic
nociceptors appears normal in adult animals despite significant
loss of nonpeptidergic DRG neurons in Ret-Nav1.8 CKO mice.
One possible explanation for this observation is that surviving
nonpeptidergic neurons elaborate additional collateral branches
in the dorsal horn to compensate for afferents that are lost with
dying neurons. Whether or not these branches form appropriate
central connections is unknown and could impact functional
changes observed in Ret-Nav1.8 CKO mice.
Loss of nonpeptidergic afferents in the epidermis is consistent
with the loss of nonpeptidergic neurons observed in Ret-Nav1.8
CKO mice. Development of epidermal innervation is dependent
on NGF/TrkA signaling and independent of GFL/Ret signaling
(Molliver et al., 1997; Patel et al., 2000). Whether the maintenance of peripheral innervation by nonpeptidergic neurons requires GFL/Ret signaling in mature mice is unknown. Although
50% of nonpeptidergic DRG neurons are lost, ⬃30% of the epidermal innervation density from nonpeptidergic fibers is maintained in Ret-Nav1.8 CKO mice, suggesting that the majority of
surviving nonpeptidergic neurons maintain target innervation in
the absence of GFL/Ret signaling. This indicates that GFL/Ret
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signaling is not invariably required for the maintenance of peripheral target innervation, although a subpopulation of surviving nonpeptidergic neurons may depend on Ret for maintenance
of peripheral projections. Interestingly, NGF/TrkA signaling is
required for the maintenance of peptidergic/TrkA fiber innervation of the epidermis in mature animals (Bennett et al., 1998a),
revealing diverse requirements for trophic factors in the maintenance of peripheral projections in peptidergic and nonpeptidergic nociceptors in mature animals.
Surprisingly, total epidermal fiber density is not decreased in
Ret-Nav1.8 CKO mice. Maintenance of normal epidermal innervation density in Ret-Nav1.8 CKO mice is not due to expansion of
TrkA/peptidergic afferents or to increased branching of surviving
nonpeptidergic afferents. Because innervation density is regulated by the amount of available trophic factor in the target field
(Kessler et al., 1983; Zwick et al., 2002; Elitt et al., 2006), other
Ret-expressing axons that respond to GFLs in the skin could
potentially extend into areas of the epidermis from which nonpeptidergic fibers are lost, leaving unoccupied target areas of
epidermis with available GFLs. Although peptidergic and nonpeptidergic fibers from small-diameter DRG neurons account for
the majority of nerve fibers in the epidermis, other fiber types are
present (Rice et al., 1998). Some of these, such as sympathetic
fibers, express Ret (Airaksinen and Saarma, 2002) and may expand in the epidermis of Ret-Nav1.8 CKO mice.
Ret-Nav1.8 CKO mice exhibit increased formalin-induced
pain
Ret-Nav1.8 CKO mice exhibit increased formalin-induced pain
behavior, suggesting that endogenous Ret signaling in nonpeptidergic nociceptors attenuates inflammation-induced pain. TMP,
a well known marker of nonpeptidergic nociceptors, was recently
identified as the transmembrane form of PAP (Zylka et al., 2008).
PAP expressed on the terminals of nonpeptidergic nociceptors in
lamina II of the dorsal horn dephosphorylates extracellular AMP
to produce the analgesic molecule adenosine, which activates
adenosine A1 receptors on lamina II neurons, producing an antinociceptive effect in models of neuropathic and inflammatory
pain (Zylka et al., 2008).
The Ret ligands GDNF (Boucher et al., 2000), ARTN (Gardell
et al., 2003), and NRTN (our unpublished data) have potent
analgesic activity in nerve-injury models of neuropathic pain.
Exogenous GDNF restores TMP activity in nonpeptidergic DRG
neurons following nerve injury (Bennett et al., 1998b). The identification of the analgesic activity of PAP in nerve injury-induced
pain suggests that regulation of PAP expression or activity may be
a mechanism by which GFLs produce analgesia after nerve injury.
In addition, PAP has analgesic activity in a model of inflammation-induced pain (Zylka et al., 2008). We found that PAP
activity is markedly reduced in the dorsal horn of Ret-Nav1.8
CKO mice (Fig. 8). Our findings suggest that regulation of PAP
may be a mechanism by which endogenous GFL/Ret signaling in
nonpeptidergic nociceptors modulates inflammation-induced
pain behavior.
Previously published studies provide conflicting information
as to whether GFLs are proalgesic or analgesic. A number of
studies have found that exogenous GFLs administered to nerveinjured animals prevent or reverse neuropathic pain (Boucher et
al., 2000; Gardell et al., 2003; Hao et al., 2003; Wang et al., 2003;
Pezet et al., 2006). However, there are conflicting reports regarding the effects of exogenous GFLs administered to normal animals. There have been reports that subcutaneous administration
of GFLs produces sensitization to noxious stimuli (Malin et al.,
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2006; Bogen et al., 2008). However, other studies have reported
that subcutaneous administration of GFLs does not alter sensory
thresholds (Boucher et al., 2000; Gardell et al., 2003; Hao et al.,
2003). Here, we focused on the role of endogenous GFL/Ret signaling in nociceptors in inflammation-induced pain. Our findings suggest that endogenous GFL/Ret signaling in nociceptors
attenuates inflammation-induced spontaneous pain. We propose that increased inflammation-induced spontaneous pain in
Ret-Nav1.8 CKO mice may be due to decreased PAP activity in
these mice. This hypothesis is based on the reported analgesic
action of PAP in models of both inflammatory and neuropathic
pain (Zylka et al., 2008). Our results do not address the possibility
that exogenous GFLs do or do not produce hyperalgesia in normal animals. Together with previous studies, our results suggest
that modulation of PAP activity may be a mechanism by which
GFL/Ret signaling produces analgesia in both inflammation- and
nerve injury-induced pain models.
In summary, our results demonstrate that Ret signaling is
required for the survival of a subpopulation of small-diameter
nonpeptidergic sensory neurons but is dispensable for the development and maintenance of central and peripheral target innervation of surviving nonpeptidergic neurons. Importantly, Ret
deletion in nonpeptidergic DRG neurons results in altered cold
sensitivity and increased pain following formalin-induced inflammation, indicating that Ret signaling modulates nociceptor
function in vivo.
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Lindfors PH, Võikar V, Rossi J, Airaksinen MS (2006) Deficient nonpeptidergic epidermis innervation and reduced inflammatory pain in glial cell
line-derived neurotrophic factor family receptor ␣2 knock-out mice.
J Neurosci 26:1953–1960.
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data
using real-time quantitative PCR and the 2(⫺⌬⌬ C(T)) method. Methods 25:402– 408.
Luo W, Wickramasinghe SR, Savitt JM, Griffin JW, Dawson TM, Ginty DD
(2007) A hierarchical NGF signaling cascade controls Ret-dependent and
Ret-independent events during development of nonpeptidergic DRG
neurons. Neuron 54:739 –754.
Malin SA, Davis BM (2008) Postnatal roles of glial cell line-derived neurotrophic factor family members in nociceptors plasticity. Sheng Li Xue Bao
60:571–578.
Malin SA, Molliver DC, Koerber HR, Cornuet P, Frye R, Albers KM, Davis
BM (2006) Glial cell line-derived neurotrophic factor family members
sensitize nociceptors in vitro and produce thermal hyperalgesia in vivo.
J Neurosci 26:8588 – 8599.
Matheson CR, Carnahan J, Urich JL, Bocangel D, Zhang TJ, Yan Q (1997)
Glial cell line-derived neurotrophic factor (GDNF) is a neurotrophic factor for sensory neurons: comparison with the effects of the neurotrophins.
J Neurobiol 32:22–32.
Mogil JS, Chesler EJ, Wilson SG, Juraska JM, Sternberg WF (2000) Sex differences in thermal nociception and morphine antinociception in rodents
depend on genotype. Neurosci Biobehav Rev 24:375–389.
Molliver DC, Wright DE, Leitner ML, Parsadanian AS, Doster K, Wen D, Yan
Q, Snider WD (1997) IB4-binding DRG neurons switch from NGF to
GDNF dependence in early postnatal life. Neuron 19:849 – 861.
Montana MC, Cavallone LF, Stubbert KK, Stefanescu AD, Kharasch ED,
Gereau RW 4th (2009) The metabotropic glutamate receptor subtype 5
antagonist fenobam is analgesic and has improved in vivo selectivity com-

3994 • J. Neurosci., March 17, 2010 • 30(11):3983–3994
pared with the prototypical antagonist 2-methyl-6-(phenylethynyl)pyridine. J Pharmacol Exp Ther 330:834 – 843.
Morales ME, Gereau RW (2009) The effects of tail biopsy for genotyping on
behavioral responses to nociceptive stimuli. PLoS One 4:e6457.
Orozco OE, Walus L, Sah DW, Pepinsky RB, Sanicola M (2001) GFR␣3 is
expressed predominantly in nociceptive sensory neurons. Eur J Neurosci
13:2177–2182.
Patel TD, Jackman A, Rice FL, Kucera J, Snider WD (2000) Development of
sensory neurons in the absence of NGF/TrkA signaling in vivo. Neuron
25:345–357.
Pezet S, McMahon SB (2006) Neurotrophins: mediators and modulators of
pain. Annu Rev Neurosci 29:507–538.
Pezet S, Krzyzanowska A, Wong LF, Grist J, Mazarakis ND, Georgievska B,
McMahon SB (2006) Reversal of neurochemical changes and painrelated behavior in a model of neuropathic pain using modified lentiviral
vectors expressing GDNF. Mol Ther 13:1101–1109.
Rice FL, Albers KM, Davis BM, Silos-Santiago I, Wilkinson GA, LeMaster
AM, Ernfors P, Smeyne RJ, Aldskogius H, Phillips HS, Barbacid M,
DeChiara TM, Yancopoulos GD, Dunne CE, Fundin BT (1998) Differential dependency of unmyelinated and A delta epidermal and upper
dermal innervation on neurotrophins, trk receptors, and p75LNGFR.
Dev Biol 198:57– 81.
Schuchardt A, D’Agati V, Larsson-Blomberg L, Costantini F, Pachnis V
(1994) Defects in the kidney and enteric nervous system of mice lacking
the tyrosine kinase receptor Ret. [See comment.] Nature 367:380 –383.
Silos-Santiago I, Molliver DC, Ozaki S, Smeyne RJ, Fagan AM, Barbacid M,

Golden et al. • Ret Function in Nociceptors
Snider WD (1995) Non-TrkA-expressing small DRG neurons are lost in
TrkA deficient mice. J Neurosci 15:5929 –5942.
Stirling LC, Forlani G, Baker MD, Wood JN, Matthews EA, Dickenson AH,
Nassar MA (2005) Nociceptor-specific gene deletion using heterozygous NaV1.8-Cre recombinase mice. Pain 113:27–36.
Stucky CL, Rossi J, Airaksinen MS, Lewin GR (2002) GFR ␣2/neurturin
signalling regulates noxious heat transduction in isolectin B4-binding
mouse sensory neurons. J Physiol 545:43–50.
Ugolini G, Marinelli S, Covaceuszach S, Cattaneo A, Pavone F (2007) The
function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. Proc Natl Acad Sci U S A 104:2985–2990.
Vogelbaum MA, Tong JX, Rich KM (1998) Developmental regulation of
apoptosis in dorsal root ganglion neurons. J Neurosci 18:8928 – 8935.
Wang R, Guo W, Ossipov MH, Vanderah TW, Porreca F, Lai J (2003) Glial
cell line-derived neurotrophic factor normalizes neurochemical changes
in injured dorsal root ganglion neurons and prevents the expression of
experimental neuropathic pain. Neuroscience 121:815– 824.
Zwick M, Davis BM, Woodbury CJ, Burkett JN, Koerber HR, Simpson JF,
Albers KM (2002) Glial cell line-derived neurotrophic factor is a survival factor for isolectin B4-positive, but not vanilloid receptor 1-positive,
neurons in the mouse. J Neurosci 22:4057– 4065.
Zylka MJ, Rice FL, Anderson DJ (2005) Topographically distinct epidermal nociceptive circuits revealed by axonal tracers targeted to Mrgprd.
Neuron 45:17–25.
Zylka MJ, Sowa NA, Taylor-Blake B, Twomey MA, Herrala A, Voikar V,
Vihko P (2008) Prostatic acid phosphatase is an ectonucleotidase and
suppresses pain by generating adenosine. Neuron 60:111–122.

